Posted by:
April 30, 2026
As Dubai Healthcare City continued to evolve as a healthcare ecosystem, a key priority was ensuring that future development aligned with both market demand and the overarching vision for quality and continuity of care.
A core challenge was the fragmented nature of healthcare data across the region, particularly across key markets such as Dubai, Abu Dhabi, Riyadh, Jeddah, Doha, Kuwait City, and Muscat. This made it difficult to consistently evaluate investor proposals and identify genuine gaps in clinical provision.
To address this, DHCC required a structured and comparable assessment of healthcare markets across the UAE (by Emirate), the wider GCC, and the broader Levant and Subcontinent regions. In parallel, there was a need to translate this analysis into a clear and accessible format that could support investor engagement and decision-making.
grmc developed a modular market intelligence framework, combining geographic depth with a consistent analytical methodology across multiple regions.
The study was structured across key modules, including socio-economic profiling, healthcare market reviews, needs analysis, gap assessment, and future market outlook. These modules were applied consistently across core markets including the UAE (Dubai, Abu Dhabi, Sharjah), Saudi Arabia (Riyadh, Jeddah), Qatar (Doha), Kuwait, Bahrain, and Oman (Muscat), as well as broader regional markets in the Levant and Subcontinent.
Each market assessment incorporated demographic analysis, disease prevalence, healthcare infrastructure mapping, and specialty-level demand evaluation. This was supported by both primary research and secondary data sources, enabling a robust and comparable view of supply and demand dynamics.
In parallel, grmc developed a comprehensive investor product kit, consolidating key findings into a structured format designed to communicate market opportunities, highlight priority medical specialities, and support the evaluation of investor-led proposals.
The engagement provided DHCC with a unified and structured view of healthcare market dynamics across multiple cities and regions. By applying a consistent methodology across geographies, the framework enabled more objective and data-driven evaluation of investor proposals, while clearly identifying priority gaps in clinical provision. The ability to benchmark cities and regions against one another added a new level of rigour to decision-making.
The investor product kit further strengthened DHCC’s positioning by translating complex market data into clear, actionable insights, supporting more targeted investor engagement and reinforcing its role as a leading hub for healthcare investment and development.
Send us a WhatsApp or please provide us with an email address and we will be in touch with you within 24 hours.
Office 607, Arenco Building No. 4, Dubai Investment Park, Dubai, UAE.
Home
Our Industries
